We are live on ! Find out more
SPRO icon

Spero Therapeutics
SPRO

80 hedge funds and large institutions have $159M invested in Spero Therapeutics in 2020 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 34 increasing their positions, 12 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

250% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 8

183% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 12

71% more capital invested

Capital invested by funds: $93.2M → $159M (+$66.1M)

33% more funds holding

Funds holding: 60 → 80 (+20)

0.44% more ownership

Funds ownership: 56.73% → 57.17% (+0.44%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

Holders
80
Holders Change
+20
Holders Change %
+33.33%
% of All Funds
1.64%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
28
Increased
34
Reduced
12
Closed
8
Calls
$19K
Puts
–
Net Calls
+$19K
Net Calls Change
+$19K

Top Buyers

Rank Fund Capital Flow
1
ACM
Aquilo Capital Management
California
+$1.4M
2
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$1.28M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$1.2M
4
Russell Investments Group
Russell Investments Group
United Kingdom
+$927K
5
MAM
Martingale Asset Management
Massachusetts
+$869K

Top Sellers

Rank Fund Capital Flow
1
VA
VR Adviser
New York
-$3.83M
2
AIC
AWM Investment Company
New York
-$1.71M
3
BI
BVF Inc
California
-$863K
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$643K
5
BCM
Bridgeway Capital Management
Texas
-$560K
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
26
Fidelity Investments
Massachusetts
$564K -$643K -57,300 -58%
Susquehanna International Group
27
Susquehanna International Group
Pennsylvania
$545K +$452K +40,250 New
Wells Fargo
28
Wells Fargo
California
$503K +$117K +10,390 +39%
Los Angeles Capital Management
29
Los Angeles Capital Management
California
$487K +$234K +20,817 +137%
Millennium Management
30
Millennium Management
New York
$487K +$246K +21,938 +156%
Charles Schwab
31
Charles Schwab
California
$480K +$45.9K +4,090 +13%
PAM
32
Panagora Asset Management
Massachusetts
$429K +$194K +17,256 +119%
Squarepoint
33
Squarepoint
New York
$398K +$101K +9,019 +44%
California Public Employees Retirement System
34
California Public Employees Retirement System
California
$394K +$327K +29,100 New
Two Sigma Investments
35
Two Sigma Investments
New York
$381K +$316K +28,150 New
Arrowstreet Capital
36
Arrowstreet Capital
Massachusetts
$375K +$311K +27,742 New
New York State Common Retirement Fund
37
New York State Common Retirement Fund
New York
$362K +$93.2K +8,300 +45%
Morgan Stanley
38
Morgan Stanley
New York
$348K +$274K +24,374 +1,746%
DADC
39
D.A. Davidson & Co
Montana
$295K +$76.3K +6,800 +45%
Ameriprise
40
Ameriprise
Minnesota
$290K +$241K +21,454 New
California State Teachers Retirement System (CalSTRS)
41
California State Teachers Retirement System (CalSTRS)
California
$283K +$12K +1,071 +5%
RhumbLine Advisers
42
RhumbLine Advisers
Massachusetts
$243K +$17K +1,512 +9%
Bank of America
43
Bank of America
North Carolina
$226K +$76.7K +6,829 +69%
Two Sigma Advisers
44
Two Sigma Advisers
New York
$221K +$183K +16,328 New
Janney Montgomery Scott
45
Janney Montgomery Scott
Pennsylvania
$196K – – –
AllianceBernstein
46
AllianceBernstein
Tennessee
$172K +$143K +12,734 New
Ohio Public Employees Retirement System (OPERS)
47
Ohio Public Employees Retirement System (OPERS)
Ohio
$157K +$84.4K +7,519 +183%
PPA
48
Parametric Portfolio Associates
Washington
$157K +$130K +11,575 New
Truist Financial
49
Truist Financial
North Carolina
$143K +$119K +10,627 New
Legal & General Group
50
Legal & General Group
United Kingdom
$142K +$99.4K +8,856 +531%
1
2
3 4

SPRO Hedge Fund Activity: Q2 2020 in Review

80 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Spero Therapeutics (SPRO) for Q2 2020, worth a combined $159M — up 71% from $93.2M a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new SPRO positions and 8 closed out — a net gain of 20 holders — while 34 added to existing stakes and 12 trimmed.

The largest buyer was Aquilo Capital Management, adding an estimated $1.4M. The largest seller was VR Adviser, exiting entirely with an estimated $3.83M sold.

  • 80 institutional investors held Spero Therapeutics (SPRO) as of Q2 2020, up from 60 in Q1 2020.
  • Funds reported $159M of Spero Therapeutics stock for Q2 2020, up 71% quarter-over-quarter.
  • 28 funds opened new Spero Therapeutics positions in Q2 2020 and 8 closed out, a net change of +20 holders.
  • The largest Spero Therapeutics buyer in Q2 2020 was Aquilo Capital Management, an estimated $1.4M added.
  • The largest Spero Therapeutics seller in Q2 2020 was VR Adviser, an estimated $3.83M sold.

Based on aggregated 13F filings for Q2 2020.